Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magali Terme

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 moleculesMagali Terme, Elena Tomasello, Koji Maruyama, et al.
Frontiers in Oncology|November 29, 2018
High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4<sup>+</sup> and CD8<sup>+</sup> T-Cell EpitopesFanny Onodi, Chahrazed Maherzi-Mechalikh, Alice Mougel, et al.
Cancer Research|July 5, 2011
IL-18 induces PD-1-dependent immunosuppression in cancerMagali Terme, Evelyn Ullrich, Laetitia Aymeric, et al.
The Journal of Experimental Medicine|January 21, 2015
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumorsThibault Voron, Orianne Colussi, Elie Marcheteau, et al.
Cancers|April 27, 2024
First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA)Jean-Louis Legoux, Roger Faroux, Nicolas Barrière, et al.
Cancers|November 13, 2021
Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer PatientsJuliette Palle, Laure Hirsch, Alexandra Lapeyre-Prost, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2017
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effectsSimon Pernot, Cecile Badoual, Magali Terme, et al.
Oncoimmunology|June 28, 2012
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancerHelene Pere, Corinne Tanchot, Jagadeesh Bayry, et al.
Cancer Research|March 20, 2012
Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cellsMagali Terme, Evelyn Ullrich, Laetitia Aymeric, et al.
The Journal of Experimental Medicine|October 19, 2005
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent mannerFrançois Ghiringhelli, Cédric Ménard, Magali Terme, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 moleculesMagali Terme, Elena Tomasello, Koji Maruyama, et al.
Frontiers in Oncology|November 29, 2018
High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4<sup>+</sup> and CD8<sup>+</sup> T-Cell EpitopesFanny Onodi, Chahrazed Maherzi-Mechalikh, Alice Mougel, et al.
Cancer Research|July 5, 2011
IL-18 induces PD-1-dependent immunosuppression in cancerMagali Terme, Evelyn Ullrich, Laetitia Aymeric, et al.
The Journal of Experimental Medicine|January 21, 2015
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumorsThibault Voron, Orianne Colussi, Elie Marcheteau, et al.
Cancers|April 27, 2024
First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA)Jean-Louis Legoux, Roger Faroux, Nicolas Barrière, et al.
Cancers|November 13, 2021
Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer PatientsJuliette Palle, Laure Hirsch, Alexandra Lapeyre-Prost, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2017
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effectsSimon Pernot, Cecile Badoual, Magali Terme, et al.
Oncoimmunology|June 28, 2012
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancerHelene Pere, Corinne Tanchot, Jagadeesh Bayry, et al.
Cancer Research|March 20, 2012
Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cellsMagali Terme, Evelyn Ullrich, Laetitia Aymeric, et al.
The Journal of Experimental Medicine|October 19, 2005
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent mannerFrançois Ghiringhelli, Cédric Ménard, Magali Terme, et al.
Pageof 5